• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Spectrum of gene mutations and clinical features in adult acute myeloid leukemia with normal karyotype].

作者信息

Huang A J, Gao L, Ni X, Hu X X, Tang G S, Cheng H, Chen J, Chen L, Liu L X, Wang C C, Zhang W P, Yang J M, Wang J M

机构信息

Department of Hematology, Institute of Hematology, the First Affiliated Hospital of Navy Military Medical University (Changhai Hospital), Shanghai 200433.

Acornmed Biotechnology Co., Ltd. Beijing, 100176.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2021 May 14;42(5):420-424. doi: 10.3760/cma.j.issn.0253-2727.2021.05.012.

DOI:10.3760/cma.j.issn.0253-2727.2021.05.012
PMID:35790467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8293012/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc2/8293012/adb58e8782ee/cjh-42-05-420-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc2/8293012/28aca0fda793/cjh-42-05-420-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc2/8293012/adb58e8782ee/cjh-42-05-420-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc2/8293012/28aca0fda793/cjh-42-05-420-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfc2/8293012/adb58e8782ee/cjh-42-05-420-g002.jpg

相似文献

1
[Spectrum of gene mutations and clinical features in adult acute myeloid leukemia with normal karyotype].[正常核型成人急性髓系白血病的基因突变谱及临床特征]
Zhonghua Xue Ye Xue Za Zhi. 2021 May 14;42(5):420-424. doi: 10.3760/cma.j.issn.0253-2727.2021.05.012.
2
[Spectrum of gene mutations and clinical features in adult acute myeloid leukemia with normal karyotype].[核型正常的成人急性髓系白血病的基因突变谱及临床特征]
Zhonghua Xue Ye Xue Za Zhi. 2021 May 14;43(5):420-423. doi: 10.3760/cma.j.issn.0253-2727.2022.05.012.
3
Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype.威尔姆斯肿瘤基因突变对埃及核型正常的急性髓系白血病患者的预后影响
Hematology. 2014 Jul;19(5):267-74. doi: 10.1179/1607845413Y.0000000129. Epub 2013 Nov 25.
4
ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.ASXL1 突变作为伴骨髓增生异常相关改变和正常核型的急性髓系白血病的替代标志物。
Cancer Med. 2020 Jun;9(11):3637-3646. doi: 10.1002/cam4.2947. Epub 2020 Mar 26.
5
Frequency of FLT3 Internal Tandem Duplications in Adult Syrian Patients with Acute Myeloid Leukemia and Normal Karyotype.FLT3 内部串联重复在伴有正常核型的成年叙利亚急性髓系白血病患者中的频率。
Asian Pac J Cancer Prev. 2021 Oct 1;22(10):3245-3251. doi: 10.31557/APJCP.2021.22.10.3245.
6
Acute myeloid leukemia with isolated del(5q) is associated with IDH1/IDH2 mutations and better prognosis when compared to acute myeloid leukemia with complex karyotype including del(5q).伴有孤立性 del(5q)的急性髓系白血病与伴有复杂核型包括 del(5q)的急性髓系白血病相比，与 IDH1/IDH2 突变相关，且预后更好。
Mod Pathol. 2020 Apr;33(4):566-575. doi: 10.1038/s41379-019-0396-4. Epub 2019 Nov 4.
7
Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.免疫表型和基因突变对染色体核型正常的老年急性髓系白血病患者的预后价值。
Hum Pathol. 2013 Jan;44(1):55-61. doi: 10.1016/j.humpath.2012.04.008. Epub 2012 Aug 28.
8
Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype.急性髓系白血病中TP53基因的突变与复杂异常核型密切相关。
Leukemia. 2008 Aug;22(8):1539-41. doi: 10.1038/leu.2008.143. Epub 2008 Jun 5.
9
Novel mutations of the nucleophosmin (NPM-1) gene in Egyptian patients with acute myeloid leukemia: a pilot study.埃及急性髓系白血病患者核磷蛋白（NPM-1）基因的新型突变：一项初步研究。
J Egypt Natl Canc Inst. 2011 Jun;23(2):73-8. doi: 10.1016/j.jnci.2011.09.003. Epub 2011 Oct 13.
10
Two Novel Mutations of the NPM1 Gene in Syrian Adult Patients with Acute Myeloid Leukemia and Normal Karyotype.两名叙利亚成人急性髓系白血病伴正常核型患者 NPM1 基因的两个新突变。
Asian Pac J Cancer Prev. 2021 Jan 1;22(1):227-232. doi: 10.31557/APJCP.2021.22.1.227.

本文引用的文献

1
Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype.高剂量化疗/白细胞介素 2 免疫疗法可能对正常核型急性髓系白血病具有临床疗效。
Hum Vaccin Immunother. 2020;16(1):109-111. doi: 10.1080/21645515.2019.1636598. Epub 2019 Jul 24.
2
Low Platelet Counts at Diagnosis Predict Better Survival for Patients with Intermediate-Risk Acute Myeloid Leukemia.低血小板计数在诊断时可预测中危急性髓系白血病患者的生存更好。
Acta Haematol. 2020;143(1):9-18. doi: 10.1159/000500230. Epub 2019 Jun 5.
3
Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia.
下一代测序技术在急性髓系白血病诊断及微小残留病评估中的应用
Haematologica. 2019 May;104(5):868-871. doi: 10.3324/haematol.2018.205955. Epub 2019 Mar 28.
4
Allogeneic hematopoietic stem cells transplantation improves the survival of intermediate-risk acute myeloid leukemia patients aged less than 60 years.异基因造血干细胞移植可改善年龄小于 60 岁的中危急性髓系白血病患者的生存。
Ann Hematol. 2019 Apr;98(4):997-1007. doi: 10.1007/s00277-018-3584-2. Epub 2019 Jan 3.
5
Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients.基于新一代测序的中国急性髓系白血病患者遗传图谱及其临床意义
Cancer Cell Int. 2018 Dec 22;18:215. doi: 10.1186/s12935-018-0716-7. eCollection 2018.
6
Preconditioning with fludarabine, busulfan and cytarabine versus standard BuCy2 for patients with acute myeloid leukemia: a prospective, randomized phase II study.氟达拉滨、白消安和阿糖胞苷预处理与标准 BuCy2 方案治疗急性髓系白血病患者的前瞻性、随机 II 期研究。
Bone Marrow Transplant. 2019 Jun;54(6):894-902. doi: 10.1038/s41409-018-0356-5. Epub 2018 Oct 19.
7
The Platelet Lifeline to Cancer: Challenges and Opportunities.血小板与癌症的生命线：挑战与机遇。
Cancer Cell. 2018 Jun 11;33(6):965-983. doi: 10.1016/j.ccell.2018.03.002. Epub 2018 Apr 12.
8
Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotype.对一种用于正常核型急性髓系白血病的新基因组分类系统的评估。
Oncotarget. 2017 Dec 22;9(4):4961-4968. doi: 10.18632/oncotarget.23575. eCollection 2018 Jan 12.
9
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1.DNMT3A、U2AF1 和 EZH2 基因突变可识别 CR1 后预后不良的中危急性髓系白血病患者。
Blood Cancer J. 2018 Jan 10;8(1):4. doi: 10.1038/s41408-017-0040-9.
10
FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern Thailand.泰国北部正常核型急性髓系白血病和骨髓增生异常综合征患者的FLT3-ITD、NPM1和DNMT3A基因突变及危险因素
Asian Pac J Cancer Prev. 2017 Nov 26;18(11):3031-3039. doi: 10.22034/APJCP.2017.18.11.3031.